These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 28725551

  • 1. Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorder.
    Combes AJE, Matthews L, Lee JS, Li DKB, Carruthers R, Traboulsee AL, Barker GJ, Palace J, Kolind S.
    Neuroimage Clin; 2017; 16():17-22. PubMed ID: 28725551
    [Abstract] [Full Text] [Related]

  • 2. Rapid myelin water imaging for the assessment of cervical spinal cord myelin damage.
    Dvorak AV, Ljungberg E, Vavasour IM, Liu H, Johnson P, Rauscher A, Kramer JLK, Tam R, Li DKB, Laule C, Barlow L, Briemberg H, MacKay AL, Traboulsee A, Kozlowski P, Cashman N, Kolind SH.
    Neuroimage Clin; 2019; 23():101896. PubMed ID: 31276928
    [Abstract] [Full Text] [Related]

  • 3. Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Jeong IH, Choi JY, Kim SH, Hyun JW, Joung A, Lee J, Kim HJ.
    Mult Scler; 2016 Oct; 22(12):1616-1620. PubMed ID: 26920375
    [Abstract] [Full Text] [Related]

  • 4. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakamura Y, Liu Z, Fukumoto S, Shinoda K, Sakoda A, Matsushita T, Hayashida S, Isobe N, Watanabe M, Hiwatashi A, Yamasaki R, Kira JI.
    Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
    [Abstract] [Full Text] [Related]

  • 5. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY, Mak HK, Chiu PW, Chang HC, Barkhof F, Chan KH.
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [Abstract] [Full Text] [Related]

  • 6. Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.
    Manogaran P, Vavasour IM, Lange AP, Zhao Y, McMullen K, Rauscher A, Carruthers R, Li DKB, Traboulsee AL, Kolind SH.
    Neuroimage Clin; 2016 Jun; 11():743-750. PubMed ID: 27330974
    [Abstract] [Full Text] [Related]

  • 7. Progressive brain microstructural damage in patients with multiple sclerosis but not in patients with neuromyelitis optica spectrum disorder: A cross-sectional and follow-up tract-based spatial statistics study.
    Chen X, Roberts N, Zheng Q, Peng Y, Han Y, Luo Q, Zeng C, Wang J, Luo T, Li Y.
    Mult Scler Relat Disord; 2021 Oct; 55():103178. PubMed ID: 34384989
    [Abstract] [Full Text] [Related]

  • 8. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S, Seddigh A, Combes A, Russell-Schulz B, Tam R, Yogendrakumar V, Deoni S, Sibtain NA, Traboulsee A, Williams SC, Barker GJ, Brex PA.
    Neuroimage Clin; 2015 Oct; 9():574-80. PubMed ID: 26594633
    [Abstract] [Full Text] [Related]

  • 9. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C, Marrodan M, González A, Chertcoff A, Osa Sanz E, Chaves H, Schteinschnaider A, Correale J, Farez MF.
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [Abstract] [Full Text] [Related]

  • 10. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
    Tatekawa H, Sakamoto S, Hori M, Kaichi Y, Kunimatsu A, Akazawa K, Miyasaka T, Oba H, Okubo T, Hasuo K, Yamada K, Taoka T, Doishita S, Shimono T, Miki Y.
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
    [Abstract] [Full Text] [Related]

  • 11. Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
    Shen T, You Y, Arunachalam S, Fontes A, Liu S, Gupta V, Parratt J, Wang C, Barnett M, Barton J, Chitranshi N, Zhu L, Fraser CL, Graham SL, Klistorner A, Yiannikas C.
    Ophthalmology; 2019 Mar; 126(3):445-453. PubMed ID: 30060979
    [Abstract] [Full Text] [Related]

  • 12. Personalized estimates of morphometric similarity in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Sun J, Zhao W, Xie Y, Zhou F, Wu L, Li Y, Li H, Li Y, Zeng C, Han X, Liu Y, Zhang N.
    Neuroimage Clin; 2023 Mar; 39():103454. PubMed ID: 37343344
    [Abstract] [Full Text] [Related]

  • 13. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH, Kwak K, Jeong IH, Hyun JW, Jo HJ, Joung A, Yu ES, Kim JH, Lee SH, Yun S, Joo J, Lee DK, Lee JM, Kim HJ.
    Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380
    [Abstract] [Full Text] [Related]

  • 14. Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Masuda H, Mori M, Uzawa A, Uchida T, Ohtani R, Kuwabara S.
    PLoS One; 2020 Dec; 15(4):e0224419. PubMed ID: 32251416
    [Abstract] [Full Text] [Related]

  • 15. Multiple sclerosis and neuromyelitis optica spectrum disorders in Malaysia: A comparison in different ethnic groups.
    Viswanathan S, Rose N, Arip M, Chai CH, Law WC, Sim R, Ong MC.
    Mult Scler Relat Disord; 2018 Oct; 25():300-308. PubMed ID: 30172173
    [Abstract] [Full Text] [Related]

  • 16. Reduced Myelin Signal in Normal-appearing White Matter in Neuromyelitis Optica Measured by 7T Magnetic Resonance Imaging.
    Chou IJ, Tanasescu R, Mougin OE, Gowland PA, Tench CR, Whitehouse WP, Gran B, Nikfekr E, Sharrack B, Mazibrada G, Constantinescu CS.
    Sci Rep; 2019 Oct 07; 9(1):14378. PubMed ID: 31591424
    [Abstract] [Full Text] [Related]

  • 17. Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.
    Mariano R, Messina S, Roca-Fernandez A, Leite MI, Kong Y, Palace JA.
    Brain; 2021 Feb 12; 144(1):198-212. PubMed ID: 33206944
    [Abstract] [Full Text] [Related]

  • 18. χ-Separation Imaging for Diagnosis of Multiple Sclerosis versus Neuromyelitis Optica Spectrum Disorder.
    Kim W, Shin HG, Lee H, Park D, Kang J, Nam Y, Lee J, Jang J.
    Radiology; 2023 Apr 12; 307(1):e220941. PubMed ID: 36413128
    [No Abstract] [Full Text] [Related]

  • 19. Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis.
    Juryńczyk M, Klimiec-Moskal E, Kong Y, Hurley S, Messina S, Yeo T, Jenkinson M, Leite MI, Palace J.
    J Neurol; 2022 Jan 12; 269(1):269-279. PubMed ID: 34043042
    [Abstract] [Full Text] [Related]

  • 20. Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography.
    Pisa M, Ratti F, Vabanesi M, Radaelli M, Guerrieri S, Moiola L, Martinelli V, Comi G, Leocani L.
    Mult Scler; 2020 Sep 12; 26(10):1197-1206. PubMed ID: 31392924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.